D-dimer Levels and Breast Cancer Progression
Author Information
Author(s): Dirix L Y, Salgado R, Weytjens R, Colpaert C, Benoy I, Huget P, van Dam P, Prové A, Lemmens J, Vermeulen P
Primary Institution: Oncology Center, AZ St-Augustinus
Hypothesis
The study investigates the relationship between plasma D-dimer levels and tumor volume, progression rate, and survival in patients with metastatic breast cancer.
Conclusion
Increased plasma D-dimer levels are associated with more rapid tumor growth and worse survival in breast cancer patients.
Supporting Evidence
- Plasma D-dimer levels were elevated in 89% of patients with progressive metastatic disease.
- D-dimer levels correlated positively with tumor load and number of metastatic sites.
- High D-dimer levels were associated with rapid tumor progression.
- Fibrinogen levels were also significantly higher in breast cancer patients.
- Serum IL-6 levels correlated with D-dimer and fibrinogen levels.
- Patients with higher D-dimer levels had worse overall survival.
- Statistical analysis showed significant correlations between D-dimer and other clinical variables.
- Overall, D-dimer levels serve as a clinically important marker for breast cancer progression.
Takeaway
This study found that higher levels of a substance called D-dimer in the blood can mean that breast cancer is getting worse and that patients might not live as long.
Methodology
The study involved three groups: healthy volunteers, patients with operable breast cancer, and patients with metastatic breast cancer, measuring various blood markers.
Potential Biases
Potential biases may arise from the selection of patient cohorts and the retrospective nature of some data.
Limitations
The study may not account for all variables affecting D-dimer levels and patient outcomes.
Participant Demographics
107 female participants, including healthy volunteers and patients with varying stages of breast cancer.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website